Allakos Inc (ALLK) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Allakos Inc
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.
Technical Indicators
|
|
|
Bearish (16)
Neutral (4)
Bullish (7)
Performance
ALLK ROI
% from 52W High
52W Low: $0.54
18 Sep 2024
52W High: $3.23
09 Jan 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
